Should glucocorticoid-induced hyperglycemia be treated in patients with septic shock?

JAMA

Volumn 303, Issue 4, 2010, Pages 365-366

  Van Den Berghe, Greet ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; FLUDROCORTISONE; GLUCOSE; HYDROCORTISONE; INSULIN; ANTIDIABETIC AGENT; ANTIINFLAMMATORY AGENT;

ADD ON THERAPY; CLINICAL PRACTICE; CLINICAL TRIAL; EDITORIAL; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN TREATMENT; INTENSIVE CARE UNIT; INTERVENTION STUDY; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PATIENT CARE; PHYSICIAN; POPULATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SAMPLE SIZE; SEPTIC SHOCK; NOTE;

ANTI-INFLAMMATORY AGENTS; BLOOD GLUCOSE; CLINICAL TRIALS AS TOPIC; FLUDROCORTISONE; HOSPITAL MORTALITY; HUMANS; HYDROCORTISONE; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; SHOCK, SEPTIC;

EID: 75749127889     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2010.41     Document Type: Editorial

References (16)

1. Annane D, Sébille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288(7):862-871.
2. Clore JN, Thurby-Hay L. Glucocorticoid-induced hyperglycemia. Endocr Pract. 2009;15(5):469-474.
3. Van den Berghe G, Schetz M, Vlasselaers D, et al. Clinical review: intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target? J Clin Endocrinol Metab. 2009;94(9):3163-3170.
4. The COIITSS Study Investigators. Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA. 2010;303(4):341-348.
5. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359-1367.
6. Schetz M, Vanhorebeek I, Wouters PJ, Wilmer A, Van den Berghe G. Tight blood glucose control is renoprotective in critically ill patients. J Am Soc Nephrol. 2008;19(3):571-578.
7. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354(5):449-461.
8. Mesotten D, Wauters J, Van den Berghe G, Wouters PJ, Milants I, Wilmer A. The effect of strict blood glucose control on biliary sludge and cholestasis in critically ill patients. J Clin Endocrinol Metab. 2009;94(7):2345-2352.
9. Hermans G, Wilmer A, Meersseman W, et al. Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. Am J Respir Crit Care Med. 2007;175(5):480-489.
10. Van den Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology. 2005;64(8):1348-1353.
11. Mesotten D, Swinnen JV, Vanderhoydonc F, Wouters PJ, Van den Berghe G. Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. J Clin Endocrinol Metab. 2004;89(1):219-226.
12. Langouche L, Vanhorebeek I, Vlasselaers D, et al. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest. 2005;115(8):2277-2286.
13. Dellinger RP, Carlet JM, Masur H, et al; Surviving Sepsis Campaign Management Guidelines Committee. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004;32(3):858-873.
14. Van den Berghe G, Wilmer A, Milants I, et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes. 2006;55(11):3151-3159.
15. Jaeschke R, Angus DC. Living with uncertainty in the intensive care unit: should patients with sepsis be treated with steroids? JAMA. 2009;301(22):2388-2390.
16. Kent DM, Trikalinos TA. Therapeutic innovations, diminishing returns, and control rate preservation. JAMA. 2009;302(20):2254-2256.